Clinical Trials on Anti-Platelet Therapy in Belgium
Total 130 results
-
Medtronic EndovascularMedtronic - MITG; Meditrial Europe Ltd.CompletedHypertension, Resistant to Conventional TherapyNetherlands, Germany, Belgium, Italy, Luxembourg, New Zealand
-
University GhentResearch Foundation FlandersRecruitingCleft Lip and Palate | Cleft Palate Children | Speech Therapy | Speech Disorders in ChildrenBelgium
-
GlaxoSmithKlineCompletedThrombocytopaeniaUnited States, Germany, Israel, Belgium, Finland, Ireland, Italy, Greece, India, Czech Republic, Hungary, Canada, Poland
-
Hasselt UniversityJessa Hospital; Ziekenhuis Netwerk Antwerpen (ZNA); Ziekenhuis Oost-Limburg; Algemeen... and other collaboratorsRecruitingDrug Use | Hepatitis C Virus Infection, Response to Therapy ofBelgium
-
University Hospital Inselspital, BerneEuropean Cardiovascular Research CenterCompletedCoronary Artery Disease | Platelet-aggregation InhibitorsBulgaria, Switzerland, Austria, Belgium, Germany, Italy, Netherlands, Poland, United Kingdom
-
University Hospital, GhentCompletedCovid-19 | Major Depressive Disorder | Electroconvulsive TherapyBelgium
-
Omeros CorporationCompletedThrombotic MicroangiopathiesUnited States, Belgium, Bulgaria, Hong Kong, Italy, Lithuania, Malaysia, New Zealand, Poland, Singapore, Taiwan, Thailand
-
BackBeat Medical IncMassachusetts General Hospital; MLM Medical Labs GmbH; nabios GmbHActive, not recruitingBradycardia | Atrioventricular Block | Hypertension Resistant to Conventional TherapyHungary, Austria, Poland, Czechia, Latvia, Belgium, Lithuania
-
University of AarhusCentre Leon Berard; University College London Hospitals; Aarhus University Hospital and other collaboratorsRecruitingEsophageal Cancer | Radiotherapy | Proton Therapy | Side EffectUnited Kingdom, France, Belgium, Denmark, Germany, Italy, Netherlands, Switzerland
-
Laboratoire français de Fractionnement et de BiotechnologiesCompletedVon Willebrand DiseaseNorway, Germany, Italy, Belgium, Czechia, Finland, Greece
-
Jules Bordet InstituteHoffmann-La RocheRecruitingMetastatic Colorectal Cancer | Unresectable Locally Advanced Colorectal Cancer | Candidate for Third-line or Subsequent Lines of TherapyBelgium, France
-
Hemab ApSRecruitingGlanzmann ThrombastheniaUnited States, Belgium, France, Italy, Netherlands, United Kingdom
-
University of LiegeCentre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire... and other collaboratorsRecruitingDysphagia | Swallowing Disorders | Disorders of Consciousness | Speech Therapy | Assessment ToolFrance, Belgium
-
Incyte CorporationCompletedPolycythemia Vera | Myelofibrosis | ThrombocythemiaSpain, United States, Germany, Austria, Belgium, Italy, Poland
-
PfizerTerminatedHealthy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Primary Immune ThrombocytopeniaSpain, United States, Belgium, United Kingdom, New Zealand
-
Alexion Pharmaceuticals, Inc.RecruitingThrombotic MicroangiopathyUnited States, Italy, Spain, Korea, Republic of, United Kingdom, Belgium, Netherlands, Germany, Japan, Greece, Brazil, Israel, France, China, Sweden, Australia, Canada, Poland
-
Eisai Inc.CompletedImmune Thrombocytopenia | Chronic ThrombocytopeniaPoland, Ukraine, Belgium, Bulgaria, South Africa, Netherlands, New Zealand, Singapore, Australia, Slovakia, Czechia
-
Eisai Inc.CompletedTreatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective ProcedureThrombocytopenia Associated With Liver DiseaseUnited States, Italy, China, Taiwan, Spain, Belgium, Poland, Portugal, Canada, Korea, Republic of, Australia, Brazil, Chile, Austria, Germany, Hungary, France, Argentina, United Kingdom, Thailand
-
AmgenCompletedImmune Thrombocytopenic PurpuraSpain, Austria, Belgium, Greece, United Kingdom, France, Germany, Netherlands
-
Eisai Inc.CompletedThrombocytopenia Associated With Liver DiseaseUnited States, China, Spain, Argentina, Belgium, Israel, Mexico, Romania, Japan, Brazil, Russian Federation, Germany, Italy, Czechia, Canada, Australia, France
-
ChemoCentryxCompletedA Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)ANCA-Associated VasculitisUnited States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
-
argenxQuintiles, Inc.CompletedPrimary Immune ThrombocytopeniaAustria, Belgium, France, Germany, Spain, Czechia, Hungary, Poland, Ukraine, United Kingdom
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedVasculitisUnited States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
-
B.C. van JaarsveldRadboud University Medical Center; UMC Utrecht; Jessa Hospital; Catharina Ziekenhuis... and other collaboratorsActive, not recruitingQuality of Life | Hemodialysis | Peritoneal Dialysis | Kidney Failure, Chronic | Informal Caregivers | Renal Replacement Therapy | Patient Reported Outcome Measures | Family Caregivers | Hemodialysis, HomeNetherlands, Belgium
-
AlexionCompletedAtypical Hemolytic-Uremic SyndromeUnited Kingdom, United States, France, Italy, Germany, Spain, Belgium
-
Novartis PharmaceuticalsCompletedBone Marrow Diseases | Hematologic Diseases | Blood Coagulation Disorders | Hemorrhagic Disorders | Primary Myelofibrosis | Myeloproliferative Disorders | Polycythemia Vera | Thrombocytosis | Essential Thrombocythemia | Blood Platelet DisordersUnited Kingdom, Belgium, Canada, France, Australia, Netherlands, Spain, Denmark, Ireland, Italy, Germany
-
Alexion PharmaceuticalsCompletedAtypical Hemolytic-Uremic SyndromeUnited Kingdom, Belgium, United States, Germany, Italy, France, Netherlands, Australia, Canada
-
Alexion Pharmaceuticals, Inc.TerminatedThrombotic MicroangiopathyUnited States, Belgium, France, Italy, Japan, Spain, Taiwan, United Kingdom, Canada, Korea, Republic of, Netherlands
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Glanzmann's DiseaseSpain, Bulgaria, Pakistan, Belgium, Germany, France, United Kingdom, Italy, Hungary, Netherlands, United States, Algeria, Austria, Sweden, Switzerland
-
Momenta Pharmaceuticals, Inc.TerminatedImmune Thrombocytopenic Purpura (ITP)United States, Poland, Hungary, Netherlands, Italy, Spain, Belgium
-
AstraZenecaActive, not recruitingEosinophilic Granulomatous VasculitisUnited States, Canada, France, Italy, Israel, United Kingdom, Japan, Germany, Belgium
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis | Post-Polycythemia Vera-MyelofibrosisBelgium, Italy, Spain, Bulgaria, Turkey, Greece, Russian Federation, Austria, Canada, Japan, Germany
-
Boston Scientific CorporationCompletedHeart Failure | Cardiovascular Disease | Heart Disease | Defibrillators, Implantable | Cardiac Resynchronization Therapy | Monitoring, PhysiologicUnited States, Spain, United Kingdom, Netherlands, Hong Kong, Denmark, France, Ireland, Australia, Belgium, Canada, Germany, Italy
-
GlaxoSmithKlineNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With PolyangiitisChurg-Strauss SyndromeUnited States, France, Japan, Spain, Italy, Germany, Canada, Belgium, United Kingdom
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
-
SanofiCompletedAcquired Thrombotic Thrombocytopenic PurpuraUnited States, Austria, Belgium, Canada, Czechia, France, Hungary, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.RecruitingVon Willebrand DiseaseUnited States, Belgium, Spain, Italy, Turkey, Germany, Austria, France, Czechia, Russian Federation, Ukraine, United Kingdom, Netherlands
-
Symphogen A/SSwedish Orphan BiovitrumCompletedImmune Thrombocytopenic PurpuraUnited States, Belgium, Germany, India, Israel, Poland, Romania, Russian Federation, Serbia, Spain, Ukraine, United Kingdom
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseNetherlands, Spain, United States, Belgium, Australia, United Kingdom, Austria, Italy, Bulgaria, Japan, Poland, Germany, India, Canada, Russian Federation, Sweden
-
Novartis PharmaceuticalsTerminatedThrombocytopaeniaUnited States, Belgium, Australia, Canada, Hong Kong, Austria, Brazil, Czechia, Israel, Russian Federation, Spain, Sweden, Thailand, Denmark, France, Germany, Ireland, Italy, Korea, Republic of, Peru, Switzerland, Taiwan, Turkey, Hungary and more
-
InflaRx GmbHCompletedGranulomatosis With Polyangiitis (GPA) | Microscopic Polyangiitis (MPA)Germany, Russian Federation, Belgium, France, Spain, Czechia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
-
GlaxoSmithKlineCompletedChurg-Strauss Syndrome | Eosinophilic Granulomatosis With PolyangiitisUnited States, France, Japan, Germany, Canada, United Kingdom, Belgium
-
SanofiRecruitingThrombotic Thrombocytopenic PurpuraItaly, Belgium, France, Greece, United States, Austria, Canada, Czechia, Germany, Japan, Netherlands, Spain, United Kingdom
-
Ablynx, a Sanofi companyCompletedAcquired Thrombotic Thrombocytopenic PurpuraUnited States, Austria, Belgium, France, Germany, Israel, Italy, Spain, Switzerland, United Kingdom, Bulgaria, Romania, Australia
-
Alexion Pharmaceuticals, Inc.CompletedAtypical Hemolytic Uremic Syndrome (aHUS)Italy, United States, Korea, Republic of, Spain, Germany, Belgium, United Kingdom
-
Novartis PharmaceuticalsCompletedMyelofibrosisBelgium, Colombia, Canada, Italy, Spain, Austria, Germany, Czechia, Thailand, Hungary, Greece, Argentina, Brazil, Israel, Russian Federation, Mexico, Portugal, South Africa, Tunisia, Slovakia, Saudi Arabia, Poland, Algeria, Ireland, Mor...
-
Scholar Rock, Inc.Active, not recruitingNeuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Anti-myostatin | Spinal Muscular Atrophy Type IIUnited States, Spain, Belgium, Germany, Netherlands, Poland, United Kingdom, Italy, France
-
AmgenCompletedImmune ThrombocytopeniaUnited States, Canada, Belgium, Czechia, Mexico, Turkey, Australia, Spain, France, Israel, Hungary, South Africa, Poland, Russian Federation, United Kingdom, Brazil, Switzerland
-
Alexion PharmaceuticalsTerminatedAtypical Hemolytic Uremic SyndromeFrance, Canada, United States, Belgium, Italy, United Kingdom, Netherlands, Australia, Austria, Germany, Sweden, Switzerland
-
argenxActive, not recruitingPrimary Immune ThrombocytopeniaUnited States, Austria, Belgium, Bulgaria, Czechia, France, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation, Spain, Turkey, United Kingdom, Ukraine